Written by Dr. Daniel Chong. Last reviewed 2026-08-05. 11 min read
The short answer, then the useful part
Mounjaro is available in Penang, it is a prescription medicine, and obtaining it is the easy part. Published prices across Malaysian clinics run roughly RM1,088 to RM3,000 a month depending on dose. What decides whether you keep the weight off is almost none of that.
This guide covers what the medication costs, what the price does not include, the regulatory position stated plainly, and the questions worth asking whoever prescribes it to you.
The regulatory position, said plainly
Tirzepatide, sold as Mounjaro, received NPRA approval in Malaysia for type 2 diabetes. Prescribing it for weight management alone is an off-label use.
Off-label prescribing is lawful, common, and often good medicine. It means a registered doctor has judged that the evidence supports using an approved drug outside its registered indication for your particular case. What it should never mean is that nobody mentioned it.
Among the semaglutide brands the distinction matters too. Ozempic is registered for type 2 diabetes; Wegovy is the brand indicated for chronic weight management. They are the same molecule at different dose ceilings.
If a clinic will not explain which of these applies to your prescription, that is worth noticing.
What it costs, and what that number leaves out
The drug price varies by dose, and the dose rises. Most patients begin at 2.5mg weekly and titrate upward over months, so the first month's cost is not the running cost. Budget for the maintenance dose, not the starter.
Then consider what the medication alone does not buy.
| What you are paying for | What it does |
|---|---|
| The medication | Reduces appetite. The part everyone quotes. |
| Baseline assessment and bloods | Establishes whether you should be on it at all, and what to monitor. |
| Body composition tracking | Distinguishes fat loss from muscle loss. A scale cannot. |
| Dietitian input | Keeps protein adequate while appetite is suppressed. This is what protects lean mass. |
| Dose titration and review | Manages nausea, adjusts pace, catches problems early. |
| Maintenance planning | Decides whether the weight stays off. Usually discussed too late. |
We have set out what a GLP-1 programme actually costs and what each part buys in detail. Our prices are published openly, so you can see the arithmetic before you commit rather than discovering it mid-consultation.
The problem nobody advertises
Weight loss is never purely fat. On a GLP-1, where appetite is suppressed precisely when protein requirements rise, the proportion of lean tissue lost can reach roughly a quarter to a third of total loss if nothing is done about it.
Losing muscle lowers resting metabolic rate, which makes regain easier. It also affects strength, function and, visibly, the face. Someone who loses twenty kilograms and a substantial share of their lean mass has not achieved what they wanted.
Three things prevent it, and none of them is a medication.
Protein, deliberately. Requirements go up during weight loss, not down. Appetite suppression makes hitting them harder exactly when they matter most. Our dietitians have written a practical guide to hitting protein targets on Malaysian food.
Resistance training. Muscle is retained by being loaded. Two or three sessions a week during active loss changes what comes off. No supplement substitutes for it.
Measuring the right thing. A scale cannot tell you what you are losing. Body composition can, and it turns an invisible problem into a visible one while there is still time to act.
What happens when you stop
Appetite returns. Without a maintenance plan, so does most of the weight, and trial data on treatment withdrawal is consistent about this.
That is not an argument against the medication. It is an argument for treating it as one phase of a programme rather than the programme itself. We build the maintenance phase in at the start, because a patient who regains the weight has paid for a temporary result.
How we run it here
Assessment first. History, relevant bloods, body composition. Whether a GLP-1 is appropriate at all, and if so which one.
Titration managed, not fixed. The climb to an effective dose is adjusted to how you tolerate it. Faster is not better, and the rate of loss affects how much lean tissue you keep.
Dietitian alongside, not afterwards. Protein targets set against your actual meals, which in Malaysia means working with hawker food rather than pretending you will stop eating it.
Composition retested at intervals. So the split between fat and lean is visible while it can still be changed.
Maintenance agreed before you need it.
Five questions worth asking any clinic
Whether you come to us or not.
Is this on-label or off-label for my case, and why? A good answer is immediate and specific.
What does the quoted price include? If it is the drug alone, ask what the rest costs.
How will you measure what I am losing? If the answer is a scale, that is the whole answer.
Who is managing my protein intake? If nobody, that is a gap.
What is the plan for when I stop? If this has not been discussed, it will be discussed too late.
When we say no
Where the clinical indication is not there. Where someone wants a prescription without assessment or monitoring. Where the expectation is a result without the protein and training work that protects it.
We would rather lose that booking than supply a medication in circumstances where it is likely to do less good than it should.
Frequently asked questions
Yes. Tirzepatide is registered with the NPRA and available through clinics in Penang, including AOKLINIK. It is a prescription medicine, so it requires assessment by a registered doctor before it can be supplied. Anyone offering it without that assessment is not operating lawfully.
Published figures across Malaysian clinics run roughly RM1,088 to RM3,000 a month depending on dose, and the dose typically increases over the first months, so the opening price is not the running cost. That is the drug alone. Assessment, blood work, body composition tracking and dietitian input sit on top, and our prices for those are published openly.
Mounjaro received NPRA approval in Malaysia for type 2 diabetes. Prescribing it for weight management alone is an off-label use, which is lawful and common under medical supervision but should be stated to you plainly rather than glossed over. Wegovy is the semaglutide brand specifically indicated for chronic weight management.
Ozempic is semaglutide, acting on the GLP-1 receptor. Mounjaro is tirzepatide, acting on both GLP-1 and GIP receptors. In trials tirzepatide produced greater average weight loss, with SURMOUNT-1 reporting up to around 22.5 per cent. It is also more expensive. Which suits you is a clinical decision, not a ranking.
Some lean tissue loss accompanies any substantial weight loss, and on a GLP-1 it can reach roughly a quarter to a third of total loss where protein intake and resistance training are neglected. This is preventable rather than inevitable, and it is the single strongest argument for supervision over simply obtaining the drug.
Appetite returns, and without a maintenance plan most of the weight follows. Trial data on treatment withdrawal is consistent on this. It is why we build the maintenance phase into the programme at the start rather than discussing it at the end.
You can find sellers, and we would advise strongly against it. Counterfeit GLP-1 pens have been reported across the region, cold chain integrity cannot be verified, and nobody is titrating your dose or checking what the weight loss is made of. The saving is real and so is the risk.
This article is general educational information and is not medical advice, a diagnosis, or an offer of treatment. GLP-1 receptor agonists are prescription medicines. In Malaysia, semaglutide (Ozempic) and tirzepatide (Mounjaro) are registered with the National Pharmaceutical Regulatory Agency for type 2 diabetes; use for weight management alone is off-label and requires individual assessment by a registered medical practitioner. Wegovy is the semaglutide brand indicated for chronic weight management. Do not start, stop or alter any prescribed medication without speaking to the doctor who prescribed it. Suitability and outcomes vary between individuals and no result can be guaranteed.